WALTHAM, Mass., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Sartorius and Repligen Corporation (NASDAQ:RGEN) today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF ...
Sartorius and Repligen launched an integrated bioreactor system that incorporates Repligen XCell ® ATF upstream intensification technology into Sartorius’ Biostat STR ® bioreactor. The goal is to ...
This session will highlight new research focused on optimizing AAV6 upstream production - an essential step in improving the safety and affordability of gene therapies. Using a design of experiment ...
Collaboration to combine the Waters™ BioAccord™ LC-MS System as a bioprocess analyzer with the Sartorius Ambr ® bioreactor system gives bioprocess scientists both faster and direct access to advanced ...
Sartorius AG is a pure play in the bioprocessing industry, dominating the single-use bioreactors market with a focus on upstream flow. Sartorius' strong customer relationships and service-first ...
In the early, anti-diluvian period of cell culture media development, cell densities in the hundreds of thousands or millions per mL were regarded as notable accomplishments. Those times are long gone ...
Bioreactor and cell retention technology integration features a single direct control interface to simplify intensified seed train implementation Customers experience optimized facility equipment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results